![David Wambeke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wambeke
Nessuna posizione attualmente
Patrimonio netto: 8 M $ in data 31/05/2026
Profilo
David John Wambeke worked at Craig-Hallum Capital Group LLC from 2007 to 2023, including the role of Partner & Managing Director in 2023.
From 2023 to 2025, worked at DiaMedica Therapeutics, Inc. as Chief Business Officer.
Attended the University of Minnesota for undergraduate studies.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2025 | 527.114 ( 0,98% ) | 3 M $ | 31/05/2026 | |
| 01/06/2024 | 527.114 ( -.--% ) | 3 M $ | 31/05/2026 | |
INEO Tech Corp.
 INEO Tech Corp. Advertising/Marketing ServicesCommercial Services Operates location-based advertising, analytics and theft detection platform for retailers 31,95% | 18/06/2026 | 103.744.300 ( 31,95% ) | 1 M $ | 31/05/2026 |
NeuroOne Medical Technologies Corp.
 NeuroOne Medical Technologies Corp. Medical SpecialtiesHealth Technology Develops thin film electrode technology for epileptic patients 1,93% | 01/03/2026 | 166.667 ( 1,93% ) | 591 668 $ | 31/05/2026 |
Precedenti posizioni note di David Wambeke
| Società | Posizione | Fine |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2025 |
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2023 |
Formazione di David Wambeke
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
